Table 4. Prevalence of sarcopenic (BMI/TBF) obesity, sarcopenia without (BMI/TBF) obesity, (BMI/TBF) obesity only, and controls phenotypes in frail and non-frailty older adults.
| Total % (n = 371) | Frailty 38.5% (n = 143) | Non-frailty 61.5% (n = 228) | p* | ||
|---|---|---|---|---|---|
| Sarcopenia and BMI obesity phenotypes | |||||
| Sarcopenic BMI obesity | 1.6 (6) | 3.5 (5) | 0.4 (1) | <0.001 | |
| Sarcopenia without BMI obesity | 18.1 (67) | 36.4 (52) | 6.6 (15) | ||
| BMI obesity only | 21.8 (81) | 14.7 (21) | 26.3 (21) | ||
| BMI controls | 58.5 (217) | 45.5 (65) | 66.2 (152) | ||
| Sarcopenia and TBF obesity phenotypes | |||||
| Sarcopenic TBF obesity | 14.3 (53) | 30.1 (43) | 4.4 (10) | <0.001 | |
| Sarcopenia without TBF obesity | 5.4 (20) | 9.8 (14) | 2.6 (6) | ||
| TBF obesity only | 67.7 (251) | 49.7 (71) | 78.9 (180) | ||
| TBF controls | 42.7 (47) | 10.5 (15) | 14.0 (32) | ||
*
Pearson's Chi-square.